Cohen LN, Rogers CC, Lloren JIC, Kamaraju S, et al. National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: The impact of the KATHERINE trial. Breast Cancer Res Treat 2025 Jun 3. doi: 10.1007/s10549-025-07750.
PMID: 40459676